Leukemia survivors
Related entities
Findings (27)
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5